PhD Studentship - Developing CRISPR-Cas Antimicrobials to Tackle Antibiotic Resistance Spread in Klebsiella pneumoniae University of Exeter in United Kingdom

[UK/Home tuition fees plus a stipend matching the UK Research Council National Minimum (£21,805 per annum for 2026/27, updated each year); additional research training and support funding of up to £5,000 per annum.] The University of Exeter is advertising a PhD studentship focused on developing CRISPR-Cas antimicrobials to tackle the spread of antibiotic resistance in Klebsiella pneumoniae . This project sits within the GW4 BioMed3 MRC Doctoral Landscape Programme , which offers up to 18 funded ...

[UK/Home tuition fees plus a Doctoral Stipend matching UK Research Council National Minimum (£21,805 per annum for 2026/27, updated each year). Additional research training and support funding of up to £5,000 per annum is also available.] The University of Exeter is offering a PhD Studentship titled Phage Power: Optimising Treatments for Bacterial Co-Infections through the GW4 BioMed3 Doctoral Landscape Programme. This project sits within a timely and important area of biomedical research, addre...

[Four-year MRC-funded studentship with UK/Home tuition fees, a Doctoral Stipend matching the UK Research Council National Minimum (£21,805 per annum for 2026/27, updated each year), and up to £5,000 per annum for additional research training and support costs.] The University of Exeter is offering a PhD Studentship titled Bacterial Pathogen Evolution during Antibiotic-Phage Combination Treatment through the GW4 BioMed3 MRC Doctoral Landscape Programme . This is a competitive doctoral studentship...

PhD Studentship: Phage Power – Optimising Treatments for Bacterial Co-Infections at the University of Exeter in the United Kingdom . This doctoral project sits within the GW4 BioMed3 MRC Doctoral Landscape Programme and focuses on phage therapy , bacterial co-infections , antibiotic resistance , and next-generation antimicrobial treatment . The research asks how phages can be used to treat infections involving multiple bacterial species and whether removing one pathogen could allow another to fl...

[Funding minimum: Home fees student. Funding maximum: International student subject to gaining an NDM studentship.] PhD Studentship at the University of Oxford focused on understanding the double life of Escherichia coli as both a benign gut commensal and a deadly pathogen. This project, based at the John Radcliffe Hospital , forms part of the wider COHORT study led by Professor Susanna Dunachie in collaboration with the Oxford Vaccine Group and the Ellison Institute of Technology . The COHORT s...